Market Tracker

04/17 6:02pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.17
Delayed Data
As of Apr 17
 -0.24 / -2.85%
Today’s Change
3.71
Today|||52-Week Range
14.21
+79.17%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close8.41
Today’s open8.40
Day’s range8.05 - 8.55
Volume213,906
Average volume (3 months)297,661
Market cap$88.4M
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-5.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.97

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp-0.04-1.07%
APRIApricus Biosciences ...-0.01-0.56%
VICLVical Inc-0.01-1.05%
BOTABiota Pharmaceutical...-0.04-1.64%
Data as of 4:00pm ET, 04/17/2015

Financials

Last reporting dateJanuary 28, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$5.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts